Protective effects of vasoactive intestinal peptide against delayed glutamate neurotoxicity in cultured retina

Brain Research

Volumn 809, Issue 1, 1998, Pages 127-136

  Shoge, Keisuke ^a   Mishima, Hiromu K ^a   Saitoh, Tomoya ^a   Ishihara, Kumatoshi ^a   Tamura, Yutaka ^b   Shiomi, Hirohito ^b   Sasa, Masashi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Department of Pharmacology   (Japan)

Author keywords

cAMP; Glutamate; Neurotoxicity; Retinal cell culture; VIP

Indexed keywords

CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP; FORSKOLIN; GLUTAMIC ACID; MEMBRANE POTENTIALS; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RETINA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032569681     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00789-6     Document Type: Article

References (41)

1. Amano T., Ujihara H., Matsubayashi H., Sasa M., Yokota T., Tamura Y., Akaike A. Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro. Brain Res. 655:1994;61-69.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
3. Audigier S., Barberis C., Jard S. Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion. Brain Res. 376:1986;363-367.
4. Brenneman D.E., Eiden L.E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1159-1162.
5. Brenneman D.E., Neale E.A., Foster G.A., d'Autremont S.W., Westbrook G.L. Nonneuronal cell mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104:1987;1603-1610.
6. Bresnick G.H. Excitotoxins: a possible new mechanism for the pathogenesis of ischemic retinal damage. Arch. Ophthalmol. 107:1989;339-341.
7. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., Hidaka H. Inhibition forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:1990;5267-5272.
8. David P., Luxky M., Teichberg V.I. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp. Eye Res. 46:1988;657-662.
9. Delbarre G., Delbarre B., Calinon F., Ferger A. Accumulation of amino acids and hydroxyl free radicals in brain and retina of gerbil after transient ischemia. J. Ocul. Pharmacol. 7:1991;147-155.
10. Eriksen E.F., Larsson L.I. Neuropeptides in the retina: evidence for differential topographical localization. Peptides. 2:1981;153-157.
11. 2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death. Eur. J. Pharmacol. 302:1996;153-162.
12. Fishbein V.A., Coy D.H., Hocart S.J., Jiang N.-Y., Mrozinski J.E. Jr., Mantey S.A., Jensen R.T. A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists. Peptides. 15:1994;95-100.
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
14. 2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6556-6560.
15. 6 pituitary cell excitability. Pflugers Arch. 411:1988;173-179.
16. Ishihara K., Alkondon M., Montes J.G., Albuquerque E.X. Ontogenically related properties of N-methyl-D-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead. J. Pharmacol. Exp. Ther. 273:1995;1459-1470.
17. Jones K.H., Senft J.A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33:1985;77-79.
18. Kaiser P.K., Lipton S.A. VIP-mediated increase in cAMP prevents tetrodotoxin-induced retinal ganglion cell death in vitro. Neuron. 5:1990;373-381.
19. Kaplan M.R., Meyer-Franke A., Lambert S., Bennett V., Duncan I.D., Levinson S.R., Barres B.A. Induction of sodium channel clustering by oligodendrocytes. Nature. 386:1997;724-728.
20. Kashii S., Takahashi M., Mandai M., Shimizu H., Honda Y., Sasa M., Ujihara H., Tamura Y., Yokota T., Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35:1994;685-695.
21. Kikuchi M., Kashii S., Honda Y., Ujihara H., Sasa M., Tamura Y., Akaike A. Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons. Invest. Ophthalmol. Vis. Sci. 36:1995;2048-2053.
22. Lorén I., Tornqvist K., Alumets J. VIP (vasoactive intestinal peptide)-immunoreactive neurons in the retina of the rat. Cell Tissue Res. 210:1980;167-170.
23. Louzada-Junior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59:1992;358-363.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol. 58:1957;193-201.
26. Mayer M.L., Westbrook G.L. The action of N-methyl-D-aspartic acid on mouse spinal neurons in culture. J. Physiol. 361:1985;65-90.
27. Morio H., Tatsuno I., Hirai A., Tamura Y., Saito Y. Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity. Brain Res. 741:1996;82-88.
28. Neal M.J., Cunningham J.R., Hutson P.H., Hogg J. Effects of ischaemia on neurotransmitter release from the isolated retina. J. Neurochem. 62:1994;1025-1033.
29. Nilsson S.F.E., Neef P.D., Robberecht P., Christophe J. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Exp. Eye Res. 58:1994;459-467.
30. Okamoto S., Okamura H., Terubayashi H., Akagi Y., Okamoto H., Ibata Y. Localization of vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in amacrine cells of rat retina. Curr. Eye Res. 11:1992;711-715.
31. Otori Y., Wei J., Barnstable C.J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 39:1998;972-981.
32. Olney J.W. The toxic effects of glutamate and related compounds in the retina and the brain. Retina. 2:1982;341-359.
33. Pachter J.A., Lam D.M. Interactions between vasoactive intestinal peptide and dopamine in the rabbit retina: stimulation of a common adenylate cyclase. J. Neurochem. 46:1986;257-264.
34. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by grial cells in vitro. Science. 277:1997;1684-1687.
35. Saitoh T., Mishima H.K., Shoge K., Ishihara K., Sasa M. Protection against glutamate neurotoxicity in retinal cultures by acidic conditions. Jpn. J. Pharmacol. 76:1998;87-95.
36. 2+ after transient elevations in clonal rat lactotrophs. Acta Physiol. Scand. 137:1989;113-123.
37. Sucher N.J., Lei S.Z., Lipton S.A. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 551:1991;297-302.
38. Terubayashi H., Tsuto T., Fukui K., Obata H.L., Okamura H., Fujisawa H., Itoi M., Yanaihara C., Yanaihara N., Ibata Y. VIP (vasoactive intestinal polypeptide)-like immunoreactive amacrine cells in the retina of the rat. Exp. Eye Res. 36:1983;743-749.
39. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885.
40. Ujihara H., Akaike A., Tamura Y., Yokota T., Sasa M., Kashii S., Honda Y. Blockade of retinal NMDA receptors by sodium nitroprusside is probably due to nitric oxide formation. Jpn. J. Pharmacol. 61:1993;375-377.
41. Yoon Y.H., Marmor M.F. Dextromethorphan protects retina against ischemic injury in vivo. Arch. Ophthalmol. 107:1989;409-411.